2022 Early-Stage Investigator Grant
Through our Early-Stage Investigator Grant Program, CCC hopes to accelerate the development of therapeutic treatments and disease-modifying advancements for those living with CHD2-related disorders. This grant program is designed to facilitate preliminary investigations that will potentially lay the groundwork for subsequent grants from the government, industry, or other funding sources, including Coalition to Cure CHD2.
CCC is interested in supporting research that advances the understanding of the cellular, molecular, genetic, and systems-level mechanisms of CHD2-related disorders. However, priority will be given to innovative projects which could potentially lead to therapeutic treatments or a cure for those with CHD2-related disorders.
Send LOI via email to firstname.lastname@example.org no later than April 15, 2022
LOIs will be reviewed and invitations for full grant proposals will be sent by May 15, 2022
Full Grant Proposals are due to email@example.com by July 11, 2022
Award Announcement will be made by no later than August 15, 2022
Research Project Start Date - immediately upon CCC’s receipt of a fully executed contract